Dominant-negative p53 mutations in rheumatoid arthritis

Area of Science:

• Molecular Biology
• Immunology
• Genetics

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation.
• The p53 tumor suppressor protein plays a critical role in cellular responses to stress and DNA damage.
• Aberrant p53 function has been implicated in various diseases, including cancer and autoimmune conditions.

Purpose of the Study:

• To investigate whether p53 mutations identified in rheumatoid arthritis (RA) synovial tissue exhibit dominant-negative activity.
• To determine the impact of these RA-derived p53 mutants on the transcriptional activity of wild-type p53.

Main Methods:

• Site-directed mutagenesis was employed to create two specific RA-derived p53 mutants (N239S and R213*).
• Human dermal fibroblasts (HS68) were transfected with wild-type p53 (wt) or mutant p53 cDNA.
• Gene expression of Interleukin-6 (IL-6) and bax, as well as bax promoter activity, were analyzed using Northern blot and reporter gene assays.

Main Results:

• Wild-type p53 (wt) increased bax mRNA levels, which was inhibited by co-transfection with RA-derived p53 mutants.
• The RA p53 mutants enhanced IL-6 gene expression.
• Mutant p53 constructs showed minimal bax promoter activity, indicating a loss of transcriptional function, and dose-dependently inhibited wt p53-mediated bax promoter activity.

Conclusions:

• At least two p53 mutants found in RA synovial tissue function as dominant negatives.
• These dominant-negative p53 mutants actively suppress the normal function of endogenous wild-type p53.
• The findings suggest a potential role for dysregulated p53 activity in the pathogenesis of rheumatoid arthritis.